A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
Llorca
Pierre-Michel
PM
Bodkin
J Alexander
JA
Spann
Melissa
M
Ball
Susan G
SG
Russell
James M
JM
Ball
Susan G
SG
D000704:Analysis of Variance; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D011569:Psychiatric Status Rating Scales; D012107:Research Design; D055502:Secondary Prevention; D013876:Thiophenes / Q000627:therapeutic use*; D013997:Time Factors
D000928:Antidepressive Agents; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride